申请人:Pfizer Inc.
公开号:US04432978A1
公开(公告)日:1984-02-21
Derivatives of 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]-indole and of (+)enantiomeric, mixtures of (+) and (-)enantiomeric or (.+-.)racemic 2,3,4,4a,5,9b-hexahydro-4a,9b-trans-1H-pyrido[4,3-b]indole, substituted at the 5-position with an aryl group and at the 2-position with a carbonylaminoalkyl group or an aminoalkyl group, are neuroleptic agents useful in the treatment of certain psychoses and neuroses.
2,3,4,5-四氢-1H-吡啶[4,3-b]-吲哚及其(+)-对映体、(+)-和(-)-对映体混合物或(.+-.)外消旋的2,3,4,4a,5,9b-六氢-4a,9b-顺式-1H-吡啶[4,3-b]吲哚的衍生物,在5位取代芳基基团和2位取代羰基氨基烷基团或氨基烷基团,是治疗某些精神病和神经症的神经阻滞剂。